Foot-and-Mouth Disease

Vaccines for Biodefense and Emerging and Neglected Diseases

Volumn , Issue , 2008, Pages 361-377

  Mason, Peter W ^a   Grubman, Marvin J ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85148793178     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369408-9.00022-6     Document Type: Chapter

References (99)

1. C.C. Abrams, A.M. King and G.J. Belsham (1995) Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J. Gen. Virol. 76(Pt 12), 3089-3098
2. R. Acharya, E. Fry, D. Stuart, G. Fox, D. Rowlands and F. Brown (1989) The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337(6209), 709-716
3. M.R. Almeida, E. Rieder, J. Chinsangaram, G. Ward, C. Beard, M.J. Grubman and P.W. Mason (1998) Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Virus Res. 55(1), 49-60
4. H.L. Bachrach, W.R. Hess and J. Callis (1955) Foot-and-mouth disease virus: its growth and cytopathogenicity in tissue culture. Science 122 1269-1270
5. H.G. Bahnemann (1990) Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine 8(4), 299-303
6. C. Beard, G. Ward, E. Rieder, J. Chinsangaram, M.J. Grubman and P.W. Mason (1999) Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J. Biotechnol. 73(2–3), 243-249
7. E. Beck and K. Strohmaier (1987) Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J. Virol. 61(5), 1621-1629
8. G.J. Belsham, C.C. Abrams, A.M. King, J. Roosien and J.M. Vlak (1991) Myristoylation of foot-and-mouth disease virus capsid protein precursors is independent of other viral proteins and occurs in both mammalian and insect cells. J. Gen. Virol. 72(Pt 3), 747-751
9. L. Benvenisti, A. Rogel, L. Kuznetzova, S. Bujanover, Y. Becker and Y. Stram (2001) Gene gun-mediate DNA vaccination against foot-and-mouth disease virus. Vaccine 19(28–29), 3885-3895
10. A. Berinstein, C. Tami, O. Taboga, E. Smitsaart and E. Carrillo (2000) Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Vaccine 18(21), 2231-2238
11. C. Biron and G.C. Sen (2001) Interferons and other cytokines. P.M. Howley, D.M. Knipe,(Eds) Field’s Virology Philadelphia: Lippincott Williams & Wilkins 321-351
12. J.L. Bittle, R.A. Houghten, H. Alexander, T.M. Shinnick, J.G. Sutcliffe, R.A. Lerner, D.J. Rowlands and F. Brown (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298(5869), 30-33
13. C. Bolwell, A.L. Brown, P.V. Barnett, R.O. Campbell, B.E. Clarke, N.R. Parry, E.J. Ouldridge, F. Brown and D.J. Rowlands (1989) Host cell selection of antigenic variants of foot-and-mouth disease virus. J. Gen. Virol. 70(Pt 1), 45-57
14. A. Bouma, A.R. Elbers, A. Dekker, A. de Koeijer, C. Bartels, P. Vellema, P. van der Wal, E.M. van Rooij, F.H. Pluimers and M.C. de Jong (2003) The foot-and-mouth disease epidemic in the Netherlands in 2001. Prev. Vet. Med. 57(3), 155-166
15. F. Brown (1992) New approaches to vaccination against foot-and-mouth disease. Vaccine 10(14), 1022-1026
16. F. Brown (2003) The history of research in foot-and-mouth disease. Virus Res. 91(1), 3-7
17. F. Brown and J. Crick (1959) Application of gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease. J. Immunol. 82 444-447
18. L. Caron, M.C.S. Brum, M.P. Moraes, W.T. Golde, C.W. Arns and M.J. Grubman (2005) The effect of granulocyte-macrophage colony-stimulating factor on the potency and efficacy of a foot-and-mouth disease virus subunit vaccine. Pesqui. Vet. Bras. 25 150-158
19. L. Cedillo-Barron, M. Foster-Cuevas, G.J. Belsham, F. Lefevre and R.M. Parkhouse (2001) Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J. Gen. Virol. 82(Pt 7), 1713-1724
20. J. Chinsangaram, C. Beard, P.W. Mason, M.K. Zellner, G. Ward and M.J. Grubman (1998) Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J. Virol. 72(5), 4454-4457
21. J. Chinsangaram, P.W. Mason and M.J. Grubman (1998) Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 16(16), 1516-1522
22. J. Chinsangaram, M.P. Moraes, M. Koster and M.J. Grubman (2003) Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol. 77 1621-1625
23. R.B. Couch, R.M. Chanock, T.R. Cate, D.J. Lang, V. Knight and R.J. Heubner (1963) Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. Am. Rev. Respir. Dis. 88 394-403
24. S.J. Cox, C. Voyce, S. Parida, S.M. Reid, P.A. Hamblin, D.J. Paton and P.V. Barnett (2005) Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx. Vaccine 23(9), 1106-1113
25. S. de Avila Botton, M.C. Brum, E. Bautista, M. Koster, R. Weiblen, W.T. Golde and M.J. Grubman (2006) Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 24(17), 3446-3456
26. R. DiMarchi, G. Brooke, C. Gale, V. Cracknell, T. Doel and N. Mowat (1986) Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232(4750), 639-641
27. T.R. Doel (2003) FMD vaccines. Virus Res. 91(1), 81-99
28. T.R. Doel, L. Williams and P.V. Barnett (1994) Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 12(7), 592-600
29. E. Domingo, C. Escarmis, E. Baranowski, C.M. Ruiz-Jarabo, E. Carrillo, J.I. Nunez and F. Sobrino (2003) Evolution of foot-and-mouth disease virus. Virus Res. 91(1), 47-63
30. M.J. Francis, G.Z. Hastings, F. Brown, J. McDermed, Y.A. Lu and J.P. Tam (1991) Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus. Immunology 73(3), 249-254
31. H.S. Frenkel (1949) Histological changes in explanted bovine epithelial tongue tissue infected with the virus of foot-and-mouth disease. Am. J. Vet. Res. 10 142-145
32. H.S. Frenkel (1950) Research on foot-and-mouth disease. II. The cultivation of the virus in explanations of tongue epithelium of bovine animals. Am. J. Vet. Res. 11 371-373
33. E.E. Fry, J.W. Newman, S. Curry, S. Najjam, T. Jackson, W. Blakemore, S.M. Lea, L. Miller, A. Burman, A.M. King and D.I. Stuart (2005) Structure of foot-and-mouth disease virus serotype A1061 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J. Gen. Virol. 86(Pt 7), 1909-1920
34. Galloway, I.A. and Nicolau, S. Histological study of the development of lesions of foot-and-mouth disease in the tongue of guinea-pig, rabbit, and ferret. In: Third Progress Report of the British Foot-and-Mouth Disease Research Committee. Great Britain Ministry of Agriculture and Fisheries, Vol. Appendix III, 1928:104–115
35. W.T. Golde, J.M. Pacheco, H. Duque, T. Doel, B. Penfold, G.S. Ferman, D.R. Gregg and L.L. Rodriguez (2005) Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 23(50), 5775-5782
36. F.L. Graham, J. Smiley, W.C. Russell and R. Nairn (1977) Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36 59-74
37. M.J. Grubman (2003) New approaches to rapidly control foot-and-mouth disease outbreaks. Expert Rev. Anti Infect. Ther. 1(4), 579-586
38. M.J. Grubman (2005) Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. Biologicals 33 227-234
39. M.J. Grubman and B. Baxt (2004) Foot-and-mouth disease. Clin. Microbiol. Rev. 17(2), 465-493
40. M.J. Grubman, S.A. Lewis and D.O. Morgan (1993) Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems. Vaccine 11(8), 825-829
41. T. Jackson, A.M. King, D.I. Stuart and E. Fry (2003) Structure and receptor binding. Virus Res. 91(1), 33-46
42. M. Kit, S. Kit, S.P. Little, R.D. Di Marchi and C. Gale (1991) Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Vaccine 9(8), 564-572
43. J.D. Kitson, K.L. Burke, L.A. Pullen, G.J. Belsham and J.W. Almond (1991) Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs. J. Virol. 65(6), 3068-3075
44. D.G. Kleid, D. Yansura, B. Small, D. Dowbenko, D.M. Moore, M.J. Grubman, P.D. McKercher, D.O. Morgan, B.H. Robertson and H.L. Bachrach (1981) Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214(4525), 1125-1129
45. N.J. Knowles and A.R. Samuel (2003) Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 91(1), 65-80
46. S. Lea, J. Hernandez, W. Blakemore, E. Brocchi, S. Curry, E. Domingo, E. Fry, R. Abu-Ghazaleh, A. King, J. Newman, et al. (1994) The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2(2), 123-139
47. S.A. Lewis, D.O. Morgan and M.J. Grubman (1991) Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J. Virol. 65(12), 6572-6580
48. F. Loeffler (1898) IV. Bericht der kommission zur erforschung der maul- und klauenseuche bei dem institut für infektionskrankheiten in Berlin. Centralblatt Bakteriologie Parasitenkunde Infektionskrankheiten 24 569-574
49. F. Loeffler (1909) Die serotherapie, die seroprophylaxe und die impfung bei maul- und klauenseuche und deren wert für die veterinärpolizei. Dtsch. Med. Wochenschr. 48 2097-2101
50. F. Loeffler and P. Frosch (1898) Berichte der kommission zur erforschung der maul- und klauenseuche bei dem institut für infektionskrankheiten in Berlin. Centralblatt Bakteriologie Parasitenkunde Infektionskrankheiten 23 371-391
51. D. Logan, R. Abu-Ghazaleh, W. Blakemore, S. Curry, T. Jackson, A. King, S. Lea, R. Lewis, J. Newman, N. Parry, et al. (1993) Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362(6420), 566-568
52. W.B. Martin and L.T. Edwards (1965) A field trial in South Africa of an attenuated vaccine against foot-and-mouth disease. Res. Vet. Sci. 36 196-201
53. P.W. Mason, M.J. Grubman and B. Baxt (2003) Molecular basis of pathogenesis of FMDV. Virus Res. 91(1), 9-32
54. P.W. Mason, M.E. Piccone, T.S. McKenna, J. Chinsangaram and M.J. Grubman (1997) Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227(1), 96-102
55. G.A. Mayr, J. Chinsangaram and M.J. Grubman (1999) Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263(2), 496-506
56. G.A. Mayr, V. O’Donnell, J. Chinsangaram, P.W. Mason and M.J. Grubman (2001) Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 19 2152-2162
57. K.C. McCullough, L. Pullen and D. Parkinson (1992) The immune response against foot-and-mouth disease virus: influence of the T lymphocyte growth factors IL-1 and IL-2 on the murine humoral response in vivo. Immunol. Lett. 31(1), 41-46
58. T.S. McKenna, J. Lubroth, E. Rieder, B. Baxt and P.W. Mason (1995) Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J. Virol. 69(9), 5787-5790
59. J. Mohler (1929) The 1929 outbreak of foot-and-mouth disease in California. J. Am. Vet. Med. Assoc. 75 309-318
60. Mohler, J.R. Foot-and-mouth disease, with special reference to the outbreak of 1914. United States Department of Agriculture, Department Circular, 1924:325
61. Mohler, J.R. and Rosenau, M.J. The origin of the recent outbreak of foot-and-mouth disease in the United States. United States Department of Agriculture, Department Circular, 1909:147
62. M.P. Moraes, J. Chinsangaram, M.C.S. Brum and M.J. Grubman (2003) Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22 268-279
63. M.P. Moraes, T. de los Santos, M. Koster, T. Turecek, H. Wang, V.G. Andreyev and M.J. Grubman (2007) Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol. 81(13), 7124-7135
64. M.P. Moraes, G.A. Mayr, P.W. Mason and M.J. Grubman (2002) Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20(11–12), 1631-1639
65. G.N. Mowat and W.G. Chapman (1962) Growth of foot-and-mouth disease virus in a fibroblastic cell line derived from hamster kidneys. Nature 194 253-255
66. F. Nargi, E. Kramer, J. Mezencio, J. Zamparo, C. Whetstone, M.H. Van Regenmortel, J.P. Briand, S. Muller and F. Brown (1999) Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptide. Vaccine 17(22), 2888-2893
67. N. Nathanson and A.D. Langmuir (1963) The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. II Relationship of poliomyelitis to Cutter vaccine. Am. J. Hyg. 78 29-60
68. K. Orsel, M.C. de Jong, A. Bouma, J.A. Stegeman and A. Dekker (2007) Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs. Vaccine 25(34), 6381-6391
69. J.M. Pacheco, M.C. Brum, M.P. Moraes, W.T. Golde and M.J. Grubman (2005) Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337(2), 205-209
70. E. Pfaff, M. Mussgay, H.O. Bohm, G.E. Schulz and H. Schaller (1982) Antibodies against a preselected peptide recognize and neutra­lize foot and mouth disease virus. EMBO J. 1(7), 869-874
71. M.E. Piccone, E. Rieder, P.W. Mason and M.J. Grubman (1995) The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 69(9), 5376-5382
72. L. Prevec, M. Schneider, K.L. Rosenthal, L.W. Belbeck, J.B. Derbyshire and F.L. Graham (1989) Use of human adenovirus-based vectors for antigen expression in animals. J. Gen. Virol. 70 429-434
73. E. Rieder, B. Baxt, J. Lubroth and P.W. Mason (1994) Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J. Virol. 68(11), 7092-7098
74. E. Rieder, T. Bunch, F. Brown and P.W. Mason (1993) Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67(9), 5139-5145
75. J. Roosien, G.J. Belsham, M.D. Ryan, A.M. King and J.M. Vlak (1990) Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J. Gen. Virol. 71(Pt 8), 1703-1711
76. D.J. Rowlands, D.V. Sangar and F. Brown (1974) A comparative chemical and serological study of the full and empty particles of foot-and-mouth disease virus. J. Gen. Virol. 26 227-238
77. W.C. Russell (2000) Update on adenovirus and its vectors. J. Gen. Virol. 81 2573-2604
78. M.M. Rweyemamu, G. Terry and T.W. Pay (1979) Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch. Virol. 59(1–2), 69-79
79. D. Sa-Carvalho, E. Rieder, B. Baxt, R. Rodarte, A. Tanuri and P.W. Mason (1997) Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71(7), 5115-5123
80. J.C. Saiz, J. Cairo, M. Medina, D. Zuidema, C. Abrams, G.J. Belsham, E. Domingo and J.M. Vlak (1994) Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization. J. Virol. 68(7), 4557-4564
81. A. Sanz-Parra, M.A. Jimenez-Clavero, M.M. Garcia-Briones, E. Blanco, F. Sobrino and V. Ley (1999) Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology 259(1), 129-134
82. A. Sanz-Parra, B. Vazquez, F. Sobrino, S.J. Cox, V. Ley and J.S. Salt (1999) Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J. Gen. Virol. 80 671-679
83. H.H. Skinner (1951) Propagation of strains of foot-and-mouth disease virus in unweaned white mice. Proc. R. Soc. Med. 44 1041-1044
84. K. Strohmaier, R. Franze and K.H. Adam (1982) Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59 295-306
85. P. Sutmoller, S.S. Barteling, R.C. Olascoaga and K.J. Sumption (2003) Control and eradication of foot-and-mouth disease. Virus Res. 91(1), 101-144
86. O. Taboga, C. Tami, E. Carrillo, J.I. Nunez, A. Rodriguez, J.C. Saiz, E. Blanco, M.L. Valero, X. Roig, J.A. Camarero, D. Andreu, M.G. Mateu, E. Giralt, E. Domingo, F. Sobrino and E.L. Palma (1997) A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71(4), 2606-2614
87. G.R. Thomson, W. Vosloo and A.D. Bastos (2003) Foot and mouth disease in wildlife. Virus Res. 91(1), 145-161
88. F.H. Top, E.L. Buescher, W.H. Bancroft and P.K. Russell (1971) Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J. Infect. Dis. 124 155-160
89. H. Vallée and H. Carré (1922) Sur la pluralite des virus aphteux. C. R. Acad. Sci. 174 1498
90. J.G. van Bekkum, H.S. Frenkel, H.H.J. Frederiks and S. Frenkel (1959) Observations on the carrier state of cattle exposed to foot-and-mouth disease virus. Tijdschr. Diergeneeskd. 84 1159-1164
91. H.G. van Rensburg, T.M. Henry and P.W. Mason (2004) Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. J. Gen. Virol. 85(Pt 1), 61-68
92. O. Waldmann and K. Trautwein (1926) Experimentelle Untersuchungen, über die Pluralität des Maul- und Klauenseuchevirus. Berl. Tierarztl. Wochenschr. 42 569-571
93. J. Wang, A. Zganiacz and Z. Xing (2002) Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation. Vaccine 20(23–24), 2887-2898
94. A. Wigdorovitz, C. Carrillo, M.J. Dus Santos, K. Trono, A. Peralta, M.C. Gomez, R.D. Rios, P.M. Franzone, A.M. Sadir, J.M. Escribano and M.V. Borca (1999) Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255(2), 347-353
95. A. Wigdorovitz, D.M. Perez Filgueira, N. Robertson, C. Carrillo, A.M. Sadir, T.J. Morris and M.V. Borca (1999) Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1. Virology 264(1), 85-91
96. H.T. Wong, S.C. Cheng, E.W. Chan, Z.T. Sheng, W.Y. Yan, Z.X. Zheng and Y. Xie (2000) Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 278(1), 27-35
97. H.T. Wong, S.C. Cheng, F.W. Sin, E.W. Chan, Z.T. Sheng and Y. Xie (2002) A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine 20(21–22), 2641-2647
98. Q. Wu, M.C.S. Brum, L. Caron, M. Koster and M.J. Grubman (2003) Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. J. Int. Cyt. Res. 23 359-368
99. A. Zibert, G. Maass, K. Strebel, M.M. Falk and E. Beck (1990) Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. J Virol 64(6), 2467-2473